Wisconsin biotech firm receives $107K NIH grant

Improvements in purification technology are needed to help researchers determine the structure and function of enzymes and other proteins that play key roles in diseases, and a Madison biotech firm has received a federal grant to enable such improvements. Semba Biosciences will get $107,000 from...

Instructors at Madison Area Technical College would like to see more women going into information technology careers. The percentage of women preparing for IT careers at MATC has dropped below 20 percent, but the college is trying to change that with a series of programs...

Fiserv has acquired a Netherlands-based maker of fraud prevention and anti-money laundering software. The acquisition of NetEconomy will enable Fiserv to offer its core processing systems with highly regarded crime-prevention software....

For technology businesses, the U.S. District Court for the Western District of Wisconsin has gained a reputation for handling cases expeditiously, and more importantly for defendants, more cost effectively than most courts. In this edition of IP Law, Madison attorney Gina Carter predicts the court...

Even though the State of Wisconsin supports the UW System, most of the “technology transfer” in Wisconsin gets done without direct state funding, notes Inside Wisconsin columnist Tom Still. Despite this lack of state support, UW-Madison and WARF rank near the top in terms of...

Leroy Hood, who this spring will be inducted into the National Inventor's Hall of Fame, has joined the board of directors of NimbleGen Systems, a Madison biotechnology firm. Hood, who gained fame by creating a DNA sequencer to map the human genome, will serve as...

Google's entry into radio advertising may have a positive effect on many marketers who aren't using radio, according to columnist Troy Janisch. In this edition of Tech/Know, Troy explains how Google has simplified local and national radio advertising for small business by integrating audio ads...

Deltanoid Pharmaceuticals will continue its development of a novel compound to reverse bone loss caused by osteoporosis. The company has initiated Phase II clinical studies to determine whether the compound, known as SMD, can improve mineral bone density in postmenopausal women. The global market for...

GenTel Biosciences, a Madison-based protein chip maker, has acquired the protein chip platform assets of GlaxoSmithKline, one of the world's largest pharmaceutical companies. The platform will position GenTel to compete for drug-screening deals in the range of $1 million to $3 million. ...